-
2
-
-
33747751307
-
Atherosclerosis in Takayasu's artritis
-
E. Seyahi, S. Uurlu, and R. Cumali Atherosclerosis in Takayasu's artritis Ann Rheum Dis 65 2006 1202 1207
-
(2006)
Ann Rheum Dis
, vol.65
, pp. 1202-1207
-
-
Seyahi, E.1
Uurlu, S.2
Cumali, R.3
-
3
-
-
58249132659
-
Overview of late outcome of medical and surgical treatment for Takayasu arteritis
-
H.M.H. Ogino, K. Minatoya, and H. Sasaki Overview of late outcome of medical and surgical treatment for Takayasu arteritis Circulation 118 2008 2738 2747
-
(2008)
Circulation
, vol.118
, pp. 2738-2747
-
-
Ogino, H.M.H.1
Minatoya, K.2
Sasaki, H.3
-
4
-
-
78649961024
-
Implication of oxidative stress and its correlation with activity of matrix metalloproteinases in patients with Takayasu's arteritis disease
-
in press; doi:10.1016/j.ijcard.2009.09.557
-
Mahajan N, Dhawan V, Malik S, Jain S. Implication of oxidative stress and its correlation with activity of matrix metalloproteinases in patients with Takayasu's arteritis disease. Int J Cardiol in press; doi:10.1016/j.ijcard.2009. 09.557.
-
Int J Cardiol
-
-
Mahajan, N.1
Dhawan, V.2
Malik, S.3
Jain, S.4
-
5
-
-
12844286997
-
Dual role of matrix metalloproteinases (matrixins) in intimal thickening and atherosclerotic plaque rupture
-
A.C. Newby Dual role of matrix metalloproteinases (matrixins) in intimal thickening and atherosclerotic plaque rupture Physiol Rev 85 2005 1 31
-
(2005)
Physiol Rev
, vol.85
, pp. 1-31
-
-
Newby, A.C.1
-
6
-
-
70449499467
-
High plasma levels of the soluble receptor for advanced glycation end products in patients with symptomatic carotid atherosclerosis
-
G. Basta, M. Castagnini, and S.D. Turco High plasma levels of the soluble receptor for advanced glycation end products in patients with symptomatic carotid atherosclerosis Eur J Clin Investig 39 2009 1065 1072
-
(2009)
Eur J Clin Investig
, vol.39
, pp. 1065-1072
-
-
Basta, G.1
Castagnini, M.2
Turco, S.D.3
-
7
-
-
74449089368
-
Circulating soluble receptor of advanced glycation end product inversely correlates with atherosclerosis in patients with chronic kidney disease
-
G. Basta, D. Leonardis, and F. Mallamaci Circulating soluble receptor of advanced glycation end product inversely correlates with atherosclerosis in patients with chronic kidney disease Kidney Int 77 2009 225 231
-
(2009)
Kidney Int
, vol.77
, pp. 225-231
-
-
Basta, G.1
Leonardis, D.2
Mallamaci, F.3
-
8
-
-
27744510124
-
Circulating levels of soluble receptor for advanced glycation end products in Alzheimer disease and vascular dementia
-
DOI 10.1001/archneur.62.11.1734
-
E. Emanuele, A. D'Angelo, and C. Tomaino Circulating levels of soluble receptor for advanced glycation end products in Alzheimer disease and vascular dementia Arch Neurol 62 2005 1734 1736 (Pubitemid 41626671)
-
(2005)
Archives of Neurology
, vol.62
, Issue.11
, pp. 1734-1736
-
-
Emanuele, E.1
D'Angelo, A.2
Tomaino, C.3
Binetti, G.4
Ghidoni, R.5
Politi, P.6
Bernardi, L.7
Maletta, R.8
Bruni, A.C.9
Geroldi, D.10
-
9
-
-
18244381813
-
Plasma levels of soluble receptor for advanced glycation end products and coronary artery disease in nondiabetic men
-
DOI 10.1161/01.ATV.0000160342.20342.00
-
C. Falcone, E. Emanuele, and A. D'Angelo Plasma levels of soluble receptor for advanced glycation end products and coronary artery disease in nondiabetic men Arterioscler Thromb Vasc Biol 25 2005 1032 1037 (Pubitemid 40627851)
-
(2005)
Arteriosclerosis, Thrombosis, and Vascular Biology
, vol.25
, Issue.5
, pp. 1032-1037
-
-
Falcone, C.1
Emanuele, E.2
D'Angelo, A.3
Buzzi, M.P.4
Belvito, C.5
Cuccia, M.6
Geroldi, D.7
-
10
-
-
24144445082
-
Decreased plasma levels of soluble receptor for advanced glycation end-products in patients with essential hypertension
-
Geroldi Dab, Falcone Cac, and Emanuele Ea Decreased plasma levels of soluble receptor for advanced glycation end-products in patients with essential hypertension J Hypertens 23 2005 1725 1729
-
(2005)
J Hypertens
, vol.23
, pp. 1725-1729
-
-
Dab, G.1
Cac, F.2
Ea, E.3
-
11
-
-
33644808985
-
Plasma level of endogenous secretory rage is associated with components of the metabolic syndrome and atherosclerosis
-
H. Koyama, T. Shoji, and H. Yokoyama Plasma level of endogenous secretory rage is associated with components of the metabolic syndrome and atherosclerosis Arterioscler Thromb Vasc Biol 25 2005 2587 2593
-
(2005)
Arterioscler Thromb Vasc Biol
, vol.25
, pp. 2587-2593
-
-
Koyama, H.1
Shoji, T.2
Yokoyama, H.3
-
12
-
-
70450228643
-
Receptor for advanced glycation end products (RAGE) and its inflammatory ligand EN-RAGE in non-diabetic subjects with pre-mature coronary artery disease
-
N. Mahajan, N. Malik, A. Bahl, and D.V. Dhawan Receptor for advanced glycation end products (RAGE) and its inflammatory ligand EN-RAGE in non-diabetic subjects with pre-mature coronary artery disease Atherosclerosis 207 2009 597 602
-
(2009)
Atherosclerosis
, vol.207
, pp. 597-602
-
-
Mahajan, N.1
Malik, N.2
Bahl, A.3
Dhawan, D.V.4
-
13
-
-
73349088102
-
Correlation among soluble markers and severity of disease in non-diabetic subjects with pre-mature coronary artery disease
-
N. Mahajan, N. Malik, A. Bahl, Y. Sharma, and V. Dhawan Correlation among soluble markers and severity of disease in non-diabetic subjects with pre-mature coronary artery disease Mol Cell Biochem 330 2009 201 209
-
(2009)
Mol Cell Biochem
, vol.330
, pp. 201-209
-
-
Mahajan, N.1
Malik, N.2
Bahl, A.3
Sharma, Y.4
Dhawan, V.5
-
14
-
-
38049063860
-
Receptor for advanced glycation endproducts and atherosclerosis: From basic mechanisms to clinical implications
-
G. Basta Receptor for advanced glycation endproducts and atherosclerosis: from basic mechanisms to clinical implications Atherosclerosis 196 2008 9 21
-
(2008)
Atherosclerosis
, vol.196
, pp. 9-21
-
-
Basta, G.1
-
15
-
-
0141727721
-
Matrix metalloproteinases as novel disease markers in Takayasu arteritis
-
A. Matsuyama, N. Sakai, and M. Ishigami Matrix metalloproteinases as novel disease markers in Takayasu arteritis Circulation 108 2003 1469 1473
-
(2003)
Circulation
, vol.108
, pp. 1469-1473
-
-
Matsuyama, A.1
Sakai, N.2
Ishigami, M.3
-
16
-
-
30344484237
-
Prognostic value of tissue inhibitor of metalloproteinase-1 for cardiovascular death among patients with cardiovascular disease: Results from the AtheroGene study
-
E. Lubos, R. Schnabel, and H.J. Rupprecht Prognostic value of tissue inhibitor of metalloproteinase-1 for cardiovascular death among patients with cardiovascular disease: results from the AtheroGene study Eur Heart J 27 2006 150 156
-
(2006)
Eur Heart J
, vol.27
, pp. 150-156
-
-
Lubos, E.1
Schnabel, R.2
Rupprecht, H.J.3
-
17
-
-
33646091277
-
Tissue inhibitor of metalloproteinase-1 (TIMP-1) is an independent predictor of all-cause mortality, cardiac mortality, and myocardial infarction
-
E.R.C. Cavusoglu, and V. Chopra Tissue inhibitor of metalloproteinase-1 (TIMP-1) is an independent predictor of all-cause mortality, cardiac mortality, and myocardial infarction Am Heart J 151 2006 1101.e1101 1101.e1108
-
(2006)
Am Heart J
, vol.151
-
-
Cavusoglu, E.R.C.1
Chopra, V.2
-
18
-
-
54049108485
-
A soluble form of the receptor for advanced glycation endproducts (RAGE) is produced by proteolytic cleavage of the membrane-bound form by the sheddase a disintegrin and metalloprotease 10 (ADAM10)
-
A. Raucci, S. Cugusi, and A. Antonelli A soluble form of the receptor for advanced glycation endproducts (RAGE) is produced by proteolytic cleavage of the membrane-bound form by the sheddase a disintegrin and metalloprotease 10 (ADAM10) FASEB J 22 2008 3716 3727
-
(2008)
FASEB J
, vol.22
, pp. 3716-3727
-
-
Raucci, A.1
Cugusi, S.2
Antonelli, A.3
-
19
-
-
58149101483
-
Receptor for advanced glycation end products is subjected to protein ectodomain shedding by metalloproteinases
-
L. Zhang, M. Bukulin, and E. Kojro Receptor for advanced glycation end products is subjected to protein ectodomain shedding by metalloproteinases J Biol Chem 283 2008 35507 35516
-
(2008)
J Biol Chem
, vol.283
, pp. 35507-35516
-
-
Zhang, L.1
Bukulin, M.2
Kojro, E.3
-
20
-
-
57549110416
-
Ethical authorship and publishing
-
A.J. Coats Ethical authorship and publishing Int J Cardiol 131 2009 149 150
-
(2009)
Int J Cardiol
, vol.131
, pp. 149-150
-
-
Coats, A.J.1
|